The evolving promise and potential of gene therapy
Publication date: July 2021Source: The Lancet Haematology, Volume 8, Issue 7Author(s): The Lancet Haematology (Source: The Lancet Haematology)
Source: The Lancet Haematology - June 23, 2021 Category: Hematology Source Type: research

CPX-351: an attractive option for the treatment of older patients with high-risk or secondary acute myeloid leukaemia
Publication date: July 2021Source: The Lancet Haematology, Volume 8, Issue 7Author(s): Xavier Thomas, Adriana Plesa (Source: The Lancet Haematology)
Source: The Lancet Haematology - June 23, 2021 Category: Hematology Source Type: research

Optical or optimal conclusion: pharmacokinetic-guided dosing in haemophilia
Publication date: July 2021Source: The Lancet Haematology, Volume 8, Issue 7Author(s): Margaret V Ragni (Source: The Lancet Haematology)
Source: The Lancet Haematology - June 23, 2021 Category: Hematology Source Type: research

Iron preparations for iron deficiency anaemia in pregnancy: which treatment is best?
Publication date: July 2021Source: The Lancet Haematology, Volume 8, Issue 7Author(s): Antonia W Shand (Source: The Lancet Haematology)
Source: The Lancet Haematology - June 23, 2021 Category: Hematology Source Type: research

Giving hereditary haemorrhagic telangiectasia the attention it deserves
Publication date: July 2021Source: The Lancet Haematology, Volume 8, Issue 7Author(s): Hanny Al-Samkari (Source: The Lancet Haematology)
Source: The Lancet Haematology - June 23, 2021 Category: Hematology Source Type: research

Sustained prothrombotic changes in convalescent patients with COVID-19
Publication date: July 2021Source: The Lancet Haematology, Volume 8, Issue 7Author(s): Fien A von Meijenfeldt, Charlotte Thålin, Ton Lisman (Source: The Lancet Haematology)
Source: The Lancet Haematology - June 23, 2021 Category: Hematology Source Type: research

Newborn screening for sickle cell disease in Africa
Publication date: July 2021Source: The Lancet Haematology, Volume 8, Issue 7Author(s): Munyaradzi Makoni (Source: The Lancet Haematology)
Source: The Lancet Haematology - June 23, 2021 Category: Hematology Source Type: research

CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a randomised, open-label, multicentre, phase 3 trial
Publication date: July 2021Source: The Lancet Haematology, Volume 8, Issue 7Author(s): Jeffrey E Lancet, Geoffrey L Uy, Laura F Newell, Tara L Lin, Ellen K Ritchie, Robert K Stuart, Stephen A Strickland, Donna Hogge, Scott R Solomon, Dale L Bixby, Jonathan E Kolitz, Gary J Schiller, Matthew J Wieduwilt, Daniel H Ryan, Stefan Faderl, Jorge E Cortes (Source: The Lancet Haematology)
Source: The Lancet Haematology - June 23, 2021 Category: Hematology Source Type: research

Perioperative pharmacokinetic-guided factor VIII concentrate dosing in haemophilia (OPTI-CLOT trial): an open-label, multicentre, randomised, controlled trial
Publication date: July 2021Source: The Lancet Haematology, Volume 8, Issue 7Author(s): Iris van Moort, Tim Preijers, Laura H Bukkems, Hendrika C A M Hazendonk, Johanna G van der Bom, Britta A P Laros-van Gorkom, Erik A M Beckers, Laurens Nieuwenhuizen, Felix J M van der Meer, Paula Ypma, Michiel Coppens, Karin Fijnvandraat, Roger E G Schutgens, Karina Meijer, Frank W G Leebeek, Ron A A Mathôt, Marjon H Cnossen, Marjon H. Cnossen, Frank W.G. Leebeek, Ron A.A. Mathôt (Source: The Lancet Haematology)
Source: The Lancet Haematology - June 23, 2021 Category: Hematology Source Type: research

Iron preparations for women of reproductive age with iron deficiency anaemia in pregnancy (FRIDA): a systematic review and network meta-analysis
Publication date: July 2021Source: The Lancet Haematology, Volume 8, Issue 7Author(s): Ewelina Rogozińska, Jahnavi Daru, Marios Nicolaides, Carmen Amezcua-Prieto, Susan Robinson, Rui Wang, Peter J Godolphin, Carlos Martín Saborido, Javier Zamora, Khalid S Khan, Shakila Thangaratinam (Source: The Lancet Haematology)
Source: The Lancet Haematology - June 23, 2021 Category: Hematology Source Type: research

Severe toxicity free survival: physician-derived definitions of unacceptable long-term toxicities following acute lymphocytic leukaemia
Publication date: July 2021Source: The Lancet Haematology, Volume 8, Issue 7Author(s): Liv Andrés-Jensen, Andishe Attarbaschi, Edit Bardi, Shlomit Barzilai-Birenboim, Deepa Bhojwani, Melanie M Hagleitner, Christina Halsey, Arja Harila-Saari, Raphaele R L van Litsenburg, Melissa M Hudson, Sima Jeha, Motohiro Kato, Leontien Kremer, Wojciech Mlynarski, Anja Möricke, Rob Pieters, Caroline Piette, Elizabeth Raetz, Leila Ronceray, Claudia Toro (Source: The Lancet Haematology)
Source: The Lancet Haematology - June 23, 2021 Category: Hematology Source Type: research

Acute lymphoblastic leukaemia presenting as euglycaemic ketoacidosis in a patient with type 1 diabetes
Publication date: July 2021Source: The Lancet Haematology, Volume 8, Issue 7Author(s): Mathilde Gavillet, Niklaus Schaefer, Anne-Karine Lapointe, Olivier Spertini, Anne Cairoli (Source: The Lancet Haematology)
Source: The Lancet Haematology - June 23, 2021 Category: Hematology Source Type: research

EHA 2021 Virtual Congress
Publication date: Available online 18 June 2021Source: The Lancet HaematologyAuthor(s): Owen Stretton (Source: The Lancet Haematology)
Source: The Lancet Haematology - June 20, 2021 Category: Hematology Source Type: research

Bleeding disorders: adapting to change
Publication date: June 2021Source: The Lancet Haematology, Volume 8, Issue 6Author(s): The Lancet Haematology (Source: The Lancet Haematology)
Source: The Lancet Haematology - May 26, 2021 Category: Hematology Source Type: research

A+AVD versus eBEACOPP in advanced-stage Hodgkin lymphoma
Publication date: June 2021Source: The Lancet Haematology, Volume 8, Issue 6Author(s): Louis F Diehl (Source: The Lancet Haematology)
Source: The Lancet Haematology - May 26, 2021 Category: Hematology Source Type: research

Maintaining the minimal: dynamics of measurable residual disease with continuous lenalidomide therapy
Publication date: June 2021Source: The Lancet Haematology, Volume 8, Issue 6Author(s): Susan Bal, Luciano J Costa (Source: The Lancet Haematology)
Source: The Lancet Haematology - May 26, 2021 Category: Hematology Source Type: research

Anti-CD25 antibody–drug conjugates: improving the delivery of death to lymphoma cells?
Publication date: June 2021Source: The Lancet Haematology, Volume 8, Issue 6Author(s): Norbert Schmitz, Georg Lenz (Source: The Lancet Haematology)
Source: The Lancet Haematology - May 26, 2021 Category: Hematology Source Type: research

Correction to Lancet Haematol 2021; 8: e185–93
Publication date: June 2021Source: The Lancet Haematology, Volume 8, Issue 6Author(s): (Source: The Lancet Haematology)
Source: The Lancet Haematology - May 26, 2021 Category: Hematology Source Type: research

Correction to Lancet Haematol 2021; 8: e205–15
Publication date: June 2021Source: The Lancet Haematology, Volume 8, Issue 6Author(s): (Source: The Lancet Haematology)
Source: The Lancet Haematology - May 26, 2021 Category: Hematology Source Type: research

PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial
Publication date: June 2021Source: The Lancet Haematology, Volume 8, Issue 6Author(s): Stefanie Kreissl, Helen Goergen, Ina Buehnen, Carsten Kobe, Alden Moccia, Richard Greil, Dennis A Eichenauer, Josée M Zijlstra, Jana Markova, Julia Meissner, Michaela Feuring-Buske, Martin Soekler, Hans-Joachim Beck, Wolfgang Willenbacher, Wolf-Dieter Ludwig, Thomas Pabst, Max S Topp, Felicitas Hitz, Martin Bentz, Ulrich Bernd Keller (Source: The Lancet Haematology)
Source: The Lancet Haematology - May 26, 2021 Category: Hematology Source Type: research

Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1): 5-year update of an international, open-label, randomised, phase 3 trial
Publication date: June 2021Source: The Lancet Haematology, Volume 8, Issue 6Author(s): David J Straus, Monika Długosz-Danecka, Joseph M Connors, Sergey Alekseev, Árpád Illés, Marco Picardi, Ewa Lech-Maranda, Tatyana Feldman, Piotr Smolewski, Kerry J Savage, Nancy L Bartlett, Jan Walewski, Radhakrishnan Ramchandren, Pier Luigi Zinzani, Martin Hutchings, Javier Munoz, Hun Ju Lee, Won Seog Kim, Ranjana Advani, Stephen M Ansell (Source: The Lancet Haematology)
Source: The Lancet Haematology - May 26, 2021 Category: Hematology Source Type: research

Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: a single-arm, single-centre, phase 2 trial
Publication date: June 2021Source: The Lancet Haematology, Volume 8, Issue 6Author(s): Benjamin Diamond, Neha Korde, Alexander M Lesokhin, Eric L Smith, Urvi Shah, Sham Mailankody, Malin Hultcrantz, Hani Hassoun, Sydney X Lu, Carlyn Tan, Even H Rustad, Francesco Maura, Kylee Maclachlan, Tim Peterson, Andriy Derkach, Sean Devlin, Heather J Landau, Michael Scordo, David J Chung, Gunjan L Shah (Source: The Lancet Haematology)
Source: The Lancet Haematology - May 26, 2021 Category: Hematology Source Type: research

Camidanlumab tesirine in patients with relapsed or refractory lymphoma: a phase 1, open-label, multicentre, dose-escalation, dose-expansion study
Publication date: June 2021Source: The Lancet Haematology, Volume 8, Issue 6Author(s): Mehdi Hamadani, Graham P Collins, Paolo F Caimi, Felipe Samaniego, Alexander Spira, Andrew Davies, John Radford, Tobias Menne, Anand Karnad, Jasmine M Zain, Paul Fields, Karin Havenith, Hans G Cruz, Shui He, Joseph Boni, Jay Feingold, Jens Wuerthner, Steven Horwitz (Source: The Lancet Haematology)
Source: The Lancet Haematology - May 26, 2021 Category: Hematology Source Type: research

CAR T-cell therapy for multiple myeloma: state of the art and prospects
Publication date: June 2021Source: The Lancet Haematology, Volume 8, Issue 6Author(s): Niels W C J van de Donk, Saad Z Usmani, Kwee Yong (Source: The Lancet Haematology)
Source: The Lancet Haematology - May 26, 2021 Category: Hematology Source Type: research

Eliminating race-based reference ranges in haematology: a call to action
Publication date: June 2021Source: The Lancet Haematology, Volume 8, Issue 6Author(s): Angela C Weyand, Patrick T McGann (Source: The Lancet Haematology)
Source: The Lancet Haematology - May 26, 2021 Category: Hematology Source Type: research

Matthew Fowler: driving advanced nursing practice in haematology
Publication date: Available online 11 May 2021Source: The Lancet HaematologyAuthor(s): Nayanah Siva (Source: The Lancet Haematology)
Source: The Lancet Haematology - May 13, 2021 Category: Hematology Source Type: research

Global collaboration led by the EBMT Nurses Group
Publication date: Available online 11 May 2021Source: The Lancet HaematologyAuthor(s): Eugenia Trigoso, Julia Ruiz, Michelle Kenyon, John Murray (Source: The Lancet Haematology)
Source: The Lancet Haematology - May 13, 2021 Category: Hematology Source Type: research

From working in the corporate world to nursing to advocacy
Publication date: Available online 11 May 2021Source: The Lancet HaematologyAuthor(s): Agnes Nsofwa (Source: The Lancet Haematology)
Source: The Lancet Haematology - May 13, 2021 Category: Hematology Source Type: research

COVID-19-associated coagulopathy and antithrombotic agents—lessons after 1 year
Publication date: Available online 27 April 2021Source: The Lancet HaematologyAuthor(s): Jenneke Leentjens, Thijs F van Haaps, Pieter F Wessels, Roger E G Schutgens, Saskia Middeldorp (Source: The Lancet Haematology)
Source: The Lancet Haematology - April 28, 2021 Category: Hematology Source Type: research

COVID-19 vaccines: building and maintaining confidence
Publication date: May 2021Source: The Lancet Haematology, Volume 8, Issue 5Author(s): The Lancet Haematology (Source: The Lancet Haematology)
Source: The Lancet Haematology - April 22, 2021 Category: Hematology Source Type: research

Sevuparin trial for acute pain in sickle cell disease: the dog that did not bark
Publication date: May 2021Source: The Lancet Haematology, Volume 8, Issue 5Author(s): Patrick Ellsworth, Jane A Little (Source: The Lancet Haematology)
Source: The Lancet Haematology - April 22, 2021 Category: Hematology Source Type: research

Surviving the storm: critical care outcomes of chimeric antigen receptor T-cell therapy
Publication date: May 2021Source: The Lancet Haematology, Volume 8, Issue 5Author(s): Janhavi Athale, Nirali N Shah (Source: The Lancet Haematology)
Source: The Lancet Haematology - April 22, 2021 Category: Hematology Source Type: research

Accurate accounting of caplacizumab cost effectiveness
Publication date: May 2021Source: The Lancet Haematology, Volume 8, Issue 5Author(s): George Goshua, Vinay Prasad, Alfred Ian Lee, Pavan K Bendapudi (Source: The Lancet Haematology)
Source: The Lancet Haematology - April 22, 2021 Category: Hematology Source Type: research

Accurate accounting of caplacizumab cost effectiveness – Authors' reply
Publication date: May 2021Source: The Lancet Haematology, Volume 8, Issue 5Author(s): Mary Hughes, Nicole Elliot, Amanda I Adler (Source: The Lancet Haematology)
Source: The Lancet Haematology - April 22, 2021 Category: Hematology Source Type: research

Sevuparin for the treatment of acute pain crisis in patients with sickle cell disease: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Publication date: May 2021Source: The Lancet Haematology, Volume 8, Issue 5Author(s): Bart J Biemond, Anil Tombak, Yurdanur Kilinc, Murtadha Al-Khabori, Miguel Abboud, Mohammed Nafea, Adlette Inati, Yasser Wali, Jens Kristensen, Jan Kowalski, Ellen Donnelly, John Ohd, Erfan Nur, Anita W. Rijneveld, Alibülent Antmen, Marvin Reid, Gabriel Ukala, Lisa Kirven-Dawes, Curis Yeates, Hugh Wong (Source: The Lancet Haematology)
Source: The Lancet Haematology - April 22, 2021 Category: Hematology Source Type: research

Outcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational cohort study
Publication date: May 2021Source: The Lancet Haematology, Volume 8, Issue 5Author(s): Élie Azoulay, Pedro Castro, Adel Maamar, Victoria Metaxa, Alice Gallo de Moraes, Louis Voigt, Florent Wallet, Kada Klouche, Muriel Picard, Anne-Sophie Moreau, Andry Van De Louw, Amélie Seguin, Djamel Mokart, Sanjay Chawla, Julien Leroy, Boris Böll, Nahema Issa, Bruno Levy, Pleun Hemelaar, Sara Fernandez (Source: The Lancet Haematology)
Source: The Lancet Haematology - April 22, 2021 Category: Hematology Source Type: research

Polyclonal hypergammaglobulinaemia: assessment, clinical interpretation, and management
Publication date: May 2021Source: The Lancet Haematology, Volume 8, Issue 5Author(s): Eric J Zhao, Catherine V Cheng, Andre Mattman, Luke Y C Chen (Source: The Lancet Haematology)
Source: The Lancet Haematology - April 22, 2021 Category: Hematology Source Type: research

The power of specialty palliative care: moving towards a systems perspective
Publication date: May 2021Source: The Lancet Haematology, Volume 8, Issue 5Author(s): Amber E Barnato, Inas S Khayal (Source: The Lancet Haematology)
Source: The Lancet Haematology - April 22, 2021 Category: Hematology Source Type: research

Ocular involvement in extranodal natural-killer T-cell lymphoma
Publication date: May 2021Source: The Lancet Haematology, Volume 8, Issue 5Author(s): Peizeng Yang, Zhenyu Zhong, Zi Ye, Jia Shu (Source: The Lancet Haematology)
Source: The Lancet Haematology - April 22, 2021 Category: Hematology Source Type: research

Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma
Publication date: Available online 19 April 2021Source: The Lancet HaematologyAuthor(s): Sarah Bird, Aikaterini Panopoulou, Robyn L Shea, Micky Tsui, Radovan Saso, Amit Sud, Sharon West, Katy Smith, John Barwood, Ewa Kaczmarek, Carmela Panlaqui, Martin Kaiser, Simon Stern, Charlotte Pawlyn, Kevin Boyd (Source: The Lancet Haematology)
Source: The Lancet Haematology - April 20, 2021 Category: Hematology Source Type: research

Will the changing therapeutic landscape meet the needs of patients with sickle cell disease?
Publication date: Available online 7 April 2021Source: The Lancet HaematologyAuthor(s): Baba Psalm Duniya Inusa, Maddalena Casale, Andrew Campbell, Natasha Archer (Source: The Lancet Haematology)
Source: The Lancet Haematology - April 8, 2021 Category: Hematology Source Type: research

Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trial
Publication date: Available online 7 April 2021Source: The Lancet HaematologyAuthor(s): Jo Howard, Kenneth I Ataga, Robert C Brown, Maureen Achebe, Videlis Nduba, Amal El-Beshlawy, Hoda Hassab, Irene Agodoa, Margaret Tonda, Sarah Gray, Joshua Lehrer-Graiwer, Elliott Vichinsky (Source: The Lancet Haematology)
Source: The Lancet Haematology - April 8, 2021 Category: Hematology Source Type: research

COVID-19 vaccines for patients with haematological conditions
Publication date: Available online 31 March 2021Source: The Lancet HaematologyAuthor(s): Clare Sun, Christopher Pleyer, Adrian Wiestner (Source: The Lancet Haematology)
Source: The Lancet Haematology - April 1, 2021 Category: Hematology Source Type: research

47th Annual Meeting of the EBMT
Publication date: Available online 31 March 2021Source: The Lancet HaematologyAuthor(s): Yaiza del Pozo Martín (Source: The Lancet Haematology)
Source: The Lancet Haematology - April 1, 2021 Category: Hematology Source Type: research

Building an understanding of transgender care
Publication date: April 2021Source: The Lancet Haematology, Volume 8, Issue 4Author(s): The Lancet Haematology (Source: The Lancet Haematology)
Source: The Lancet Haematology - March 24, 2021 Category: Hematology Source Type: research

2 + 2 in the long term: informing a new standard of care in 2021 for early stage, unfavourable Hodgkin lymphoma
Publication date: April 2021Source: The Lancet Haematology, Volume 8, Issue 4Author(s): Nicole Wong Doo, Judith Trotman (Source: The Lancet Haematology)
Source: The Lancet Haematology - March 24, 2021 Category: Hematology Source Type: research

Looking long-term: an unmet need in immune thrombocytopenia
Publication date: April 2021Source: The Lancet Haematology, Volume 8, Issue 4Author(s): Cindy Neunert (Source: The Lancet Haematology)
Source: The Lancet Haematology - March 24, 2021 Category: Hematology Source Type: research

Model solutions for ethical allocation during cancer medicine shortages
Publication date: April 2021Source: The Lancet Haematology, Volume 8, Issue 4Author(s): Andrew Hantel, Jeff Peppercorn, Gregory A Abel (Source: The Lancet Haematology)
Source: The Lancet Haematology - March 24, 2021 Category: Hematology Source Type: research

Correction to Lancet Haematol 2020; 7: e112–21
Publication date: April 2021Source: The Lancet Haematology, Volume 8, Issue 4Author(s): (Source: The Lancet Haematology)
Source: The Lancet Haematology - March 24, 2021 Category: Hematology Source Type: research

Correction to Lancet Haematol 2021: 8: e254–66
Publication date: April 2021Source: The Lancet Haematology, Volume 8, Issue 4Author(s): (Source: The Lancet Haematology)
Source: The Lancet Haematology - March 24, 2021 Category: Hematology Source Type: research